Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO

New Delhi: Drug firm Sanofi India on Tuesday reported 37.27 per cent rise in net profit to Rs 82.5 crore for the quarter ended March 31, 2018.

The company had posted a net profit of Rs 60.1 crore in January-March period of 2016-17, Sanofi India said in a filing to BSE.

Total revenue from operations also rose to Rs 617.7 crore as against Rs 552.9 crore earlier, it added.

In a separate filing , the company said its board has approved appointment of Charles Billard as Chief Financial Officer and key Managerial Personnel with effect from July 1, 2018.

Shares of Sanofi India were today trading at Rs 4,890.85 per scrip on BSE, up 1.17 per cent from its previous close.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India